
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Financière de Tubize
Market Cap: €8.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€184.80
7D
-3.4%
1Y
15.5%
Hyloris Pharmaceuticals
Market Cap: €125.7m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.49
7D
-0.9%
1Y
-29.8%